Compare CTKB & CEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTKB | CEVA |
|---|---|---|
| Founded | 1990 | 1999 |
| Country | United States | United States |
| Employees | 688 | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 652.1M | 573.9M |
| IPO Year | 2021 | 2000 |
| Metric | CTKB | CEVA |
|---|---|---|
| Price | $5.09 | $21.71 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $5.88 | ★ $34.20 |
| AVG Volume (30 Days) | ★ 1.2M | 665.5K |
| Earning Date | 11-05-2025 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $196,828,000.00 | $107,530,000.00 |
| Revenue This Year | N/A | $4.34 |
| Revenue Next Year | $5.62 | $13.26 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 5.55 |
| 52 Week Low | $2.37 | $18.23 |
| 52 Week High | $7.30 | $38.94 |
| Indicator | CTKB | CEVA |
|---|---|---|
| Relative Strength Index (RSI) | 54.29 | 46.36 |
| Support Level | $4.71 | $21.32 |
| Resistance Level | $5.19 | $22.15 |
| Average True Range (ATR) | 0.21 | 0.92 |
| MACD | -0.01 | 0.16 |
| Stochastic Oscillator | 84.00 | 42.87 |
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.
CEVA Inc is a licensor of signal-processing intellectual property. Through partnerships with semiconductor companies and original equipment manufacturers globally, the company helps produce devices for a range of end markets. OEMs and semiconductor companies choose to sell products with CEVA equipment to wireless, consumer, automotive, and Internet of Things companies. Revenue is derived primarily from licensing fees and related revenue, and royalties generated from the shipments of products utilizing its intellectual properties. CEVA also engages in the training and sale of development systems.